Tarbox Family Office, Inc. Caladrius Biosciences, Inc. Transaction History

Tarbox Family Office, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$0.41 - $0.74 $4,732 - $8,541	11,542 New	11,542 $6,000
Q2 2019 Aug 02, 2019	SELL	$2.25 - $3.6 $25,969 - $41,551	-11,542 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$4.85 - $6.5 $55,978 - $75,023	11,542 New	11,542 $68,000
Q2 2018 Jul 31, 2018	SELL	$3.8 - $8.64 $367,334 - $835,202	-96,667 Closed	0 $0
Q3 2017 Oct 19, 2017	BUY	$3.58 - $4.34 $346,067 - $419,534	96,667	96,667 $0

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.